Elite Pharmaceuticals, Inc. Deferred Income Tax Assets, Net
Elite Pharmaceuticals, Inc. (ELTP) had Deferred Income Tax Assets, Net of $6.50 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:DeferredIncomeTaxAssetsNet · last filed 2026-08-13
- 2026-06-30: Deferred Income Tax Assets, Net $6.50M.
- 2026-03-31: Deferred Income Tax Assets, Net $7.82M.
- 2025-12-31: Deferred Income Tax Assets, Net $10.33M.
- 2025-09-30: Deferred Income Tax Assets, Net $11.80M.
| Period end | Deferred Income Tax Assets, Net |
|---|---|
| 2026-06-30 | $6.50M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $7.82M 10-Q · filed 2026-08-13 |
| 2025-12-31 | $10.33M 10-Q · filed 2026-02-17 |
| 2025-09-30 | $11.80M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $13.48M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $18.37M 10-K · filed 2026-06-29 |
| 2024-12-31 | $20.69M 10-Q · filed 2025-02-13 |
| 2024-09-30 | $20.84M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $22.14M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $22.16M 10-K · filed 2025-06-30 |
| 2023-12-31 | $20.23M 10-Q · filed 2024-02-14 |
| 2023-09-30 | $19.43M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $2.17M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $2.17M 10-K · filed 2024-07-01 |
| 2022-12-31 | $2.17M 10-Q · filed 2023-02-14 |
| 2022-09-30 | $2.17M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $2.17M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $2.17M 10-K · filed 2023-06-29 |